Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil

NCT00625079 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped inclusion/exclusion criteria limited enrollment

Conditions

Pulmonary Arterial Hypertension
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Pulmonary Hypertension

Interventions

DRUG: sildenafil

Sponsor

University of California, Los Angeles

Collaborators

[object Object]